Difference between revisions of "Anesthetics"
Jump to navigation
Jump to search
Mfrdmanager (talk | contribs) (Created page with "==Section 8 - MEDICATION GUIDELINES== ===8.03 ANESTHETICS=== ====Pontocaine Ophthalmic / Local anesthetic==== '''DESCRIPTION''' * Ophthalmic anesthetic. '''INDICATIONS''' * R...") |
Mfrdmanager (talk | contribs) m (Protected "Anesthetics" ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite))) |
(No difference)
|
Revision as of 10:16, 10 February 2018
Contents
Section 8 - MEDICATION GUIDELINES
8.03 ANESTHETICS
Pontocaine Ophthalmic / Local anesthetic
DESCRIPTION
- Ophthalmic anesthetic.
INDICATIONS
- Removal of foreign objects, tonometry.
CONTRAINDICATIONS
- It should not be administered in the presence potential penetrating eye injury. Allergy or sensitivity to PABA.
PRECAUTIONS
- Thorough history must be obtained to rule out penetrating injury.
DOSAGE
- 1-2 gtts - adult and children. Instill in lower conjunctival cornix.
Ketamine / Anesthetic
DESCRIPTION
- Dissociative anesthetic, Systemic. Schedule III controlled substance.
INDICATIONS
- Sedation in the extremely agitated patient
CONTRAINDICATIONS
- Hypersensitivity
- Penetrating eye injury.
- Pregnancy
- Due to sympathomimetic effects, contraindicated in patients with known, severe CAD (for example, patients currently experiencing STEMI).
PRECAUTIONS
- Have ventilatory support readily available
- There is no known antidote or reversal agent for Ketamine
- Emergence Reaction - Read "Special Note" at RxList - Ketamine
- If this occurs give Benzodiazepine.
- DIAZEPAM (VALIUM) 2 - 20 mg SLOW IVP or IM to desired effect.
- MIDAZOLAM (VERSED) 2 - 10 mg IV, IO or IN, titrated to effect.
- If this occurs give Benzodiazepine.
DOSAGE
- 2 mg/kg SLOW IVP OR 4 mg/kg IM, 1 dose
Onset of action:
- IM administration: 3 – 5 minutes
- IV administration: 1- 2 minutes
Duration of action:
- 20 – 40 minutes when dosed at 4mg/kg IM.
- 12 – 20 minutes when dosed at 2mg/kg IV.
Side Effects:
- Hypertension, emesis, laryngospasm, tachycardia, bronchodilation, increased salivation, emergence reaction (12%).